-
Bayer plans to shift focus away from women’s health drug research
FOX Company correspondent Lydia Hu has the most recent on the antibiotic scarcity on ‘Varney & Co.’ Bayer, 1 of the world’s major pharmaceutical organizations, introduced on Friday that it will be shifting its focus absent from women’s wellness. The enterprise plans to set much more study efforts into rare conditions, cardiovascular disorder, neurology, oncology and immunology. “When it will come to investigate and the subsequent clinical phases, we will no for a longer time have an express concentration on women’s health and fitness,” the head of Bayer’s prescription drugs unit, Stefan Oelrich, instructed Reuters. BE Effectively: SPRING-Clean up YOUR Medication Cabinet TO Take away EXPIRED Medications On the other…